Mena FN

Leukotriene Modifiers Market Projected To Hit $29.25 Billion By 2029

(MENAFN- EIN Presswire) EINPresswire/ -- The leukotriene modifiers market is gaining significant traction as advancements in healthcare and growing awareness among patients and professionals drive ...
Medscape

Can Leukotriene Modifiers Benefit Severe Drug-Induced Skin Reactions?

This question addresses the use of leukotriene receptor antagonists, such as montelukast, in drug-induced skin reactions. Currently there are few or no conclusive data on the use of leukotriene ...
FierceBiotech

FDA Requests Labeling Change for Leukotriene Modifiers

The U.S. Food and Drug Administration today provided further updated safety information on a class of asthma drugs known as leukotriene modifiers. The FDA has requested that manufacturers include a ...
Medscape

Comparison of Inhaled Salmeterol and Oral Zafirlukast in Asthmatic Patients Using Concomitant Inhaled Corticosteroids

Context: For asthmatic patients who remain symptomatic on inhaled corticosteroids, augmenting the therapy with additional long-term control medication is advocated. Long-acting ß 2-adrenergic agonists ...